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 INTRODUCTION
Progressive glomerular sclerosis (PGS) is
a condition that results from a variety of glo-
merular injuries and is characterized by the
prominent pathological features of accumu-
lation of glomerular extracellular matrix
(ECM) and decrease in the number of
glomerular cells. Whilst the mechanisms res-
ponsible for the accumulation of glomerular
extracellular matrix have been well studied and
are thought to involve growth factors such as
transforming growth factor-b,1,2 the mecha-
nisms involved in the progressive loss of
glomerular cells are less well understood.3,4
One possible mechanism for the observed
decrease in the number of glomerular cells may
involve the process of apoptosis.2,5,6
Apoptosis (also referred to as programmed
cell death) is a genetically programmed series
of events that, through activation of a final
common biochemical pathway, ultimately
leads to the dismantling of the cell into easily
digestible membrane-intact packages (with the
notable absence of the inflammation that is
common in necrosis).5,7 Morphologically,
apoptosis is defined by a shrinkage in cell
volume and the dissociation of the cell from
its neighbors, maintenance of the integrity of
intracellular organelles and the plasma
membrane, and most distinctively, the
condensation of nuclear chromatin. In the
final stages of apoptosis, the condensed nu-
cleus fragments to form membrane-bound
vesicles (apoptotic bodies), which are then
phagocytosed by neighboring cells.7
The principle mediators in the apoptotic
pathway are a class of protease enzymes called
caspases.8-10 These enzymes derive their name
from the fact that they all have cysteine in their
active site and cleave their target proteins at
specific aspartic acids.8
 Whilst there are no caspase inhibitors that
are currently available for therapeutic use,
there are currently two classes of protease
inhibitors that have been utilized in the
treatment of some pathologies; the inhibitors
of the HIV-1 viral protease and angiotensin-
converting enzyme inhibitors. It is not known
how these drugs may affect the caspase cascade
and therefore whether they would be effective
in preventing excessive apoptosis and thus
glomerular cell loss in the late stages of
progressive glomerular sclerosis.
Our aim was therefore to evaluate whether
an inhibitor of the HIV-1 viral protease (Ac-
Leu-Val-phenylalanine) could inhibit apop-
tosis in immortalized mesangial cells.
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METHODS
Immortalized mesangial cells (CRL-
1927), were obtained from the American
Type of Culture Collection (ATCC) and
were cultured from passages 43 to 50 in
Dulbecco’s Modified Eagle Medium
(DMEM), supplemented with fetal bovine
serum (FBS; 5%), NaHCO
3
 (2 g/l), HEPES
(2.6 g/l), penicillin (10,000 IU/l) and
streptomycin (50 mg/ml). Cells were
cultured in either polystyrene bottles or 24-
well culture plates at 37°C in a humidified
gas mixture (95% air and 5% CO
2
).
Cell viability was assessed by the exclusion
of the fluorescent dyes acridine orange (AO)
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CONTEXT: Progressive glomerular sclerosis is a
condition characterized by the accumulation of
glomerular extracellular matrix and a decrease in
the number of glomerular cells. The mechanisms
involved in the progressive loss of glomerular cells
are not well understood but may involve the process
of apoptosis. The principal mediators for the
apoptotic pathway are a class of protease enzymes
called caspases. It is not known how other thera-
peutic protease inhibitors affect the caspase
cascade and therefore whether they would be
effective in preventing excessive apoptosis in the
late stages of progressive glomerular sclerosis.
OBJECTIVE: To evaluate whether an inhibitor of the HIV-
1 viral protease Ac-Leu-Val-phenylalanine (PI) could
inhibit apoptosis in immortalized mesangial cells.
DESIGN: Experimental.
SETTING: Nephrology Division, Universidade Federal
de São Paulo/Escola Paulista de Medicina.
PARTICIPANTS: Immortalized mesangial cells.
PROCEDURES: Cell culture.
MAIN MEASUREMENTS: Viability and rate of
apoptosis.
RESULTS: Immortalized mesangial cells were treated
with staurosporine (at concentrations of 10-100 nM
for 8-28 hours) to induce apoptosis. Staurosporine
at 10 nM for 8 hours had no effect on viability, but
did cause a significant increase in the rate of
apoptosis (p = 0.0411, n = 6). Increasing the
incubation time elicited a greater increase in the
rate of apoptosis (p = 0.0001, n = 6), although
there was also a significant decrease in viability
(p=0.0002). Increasing the concentration of
staurosporine to 100 nM resulted in a marked
increase in apoptosis (p <0.0001) but resulted in
unacceptable viability (<40%, p <0.0001, n = 6).
CONCLUSIONS: Incubation of immortalized mesangial
cells with PI (900 nM) alone for 2-24 hours had no
effect on cell viability or the rate of apoptosis when
compared with vehicle (methanol) controls. Co-
incubation of the cells with staurosporine (10 nM)
and PI for 24 hours had no significant effect on the
rate of apoptosis. Therefore, in immortalized
mesangial cells, staurosporine-induced apoptosis
was not significantly affected by the HIV-1 viral
protease inhibitor Ac-Leu-Val-phenylalanine.
KEY WORDS: Immortalized mesangial cell.
Progressive glomerular sclerosis. Apoptosis.
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determined morphologically using a fluo-
rochrome [bis-benzimide Hoe 33342 (2’-
(ethoxyphenyl)-5-(4-methyl-1-piperazinyl)-
2,5’-bis-benzimidazole, HCl)] (HOE 33342,
50 µg/ml). Cells presenting with condensed
nuclei and/or apoptotic bodies were counted
as positive for apoptosis.
 Previously, protein kinase inhibition had
been shown to lead to apoptosis in many
different cell types.12 The mechanism by which
this occurs is believed to be via arresting cells
at the G1 checkpoint.12 We used the broad
spectrum protein kinase inhibitor stauros-
porine (shown to inhibit CaM kinase, myosin
light-chain kinase, protein kinase A, protein
kinase C and protein kinase G) to induce
apoptosis in immortalized mesangial cells.
Cells were treated with 10-100 nM of stau-
rosporine for 8-28 hours and then their via-
bility and apoptosis were assessed.
Sao Paulo Med J/Rev Paul Med 2002;120(3):81-3.
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RESULTS
Treatment of immortalized mesangial
cells with staurosporine at 10 nM for 8 hours
caused no significant difference in viability
when compared with vehicle (DMSO)
controls (Figure 1), but did elicit a small
increase in the rate of apoptosis (p = 0.0411,
n = 6; Figure 1). When the incubation time
was increased to 24 hours, staurosporine at
10 nM caused a significant decrease in
viability (p = 0.0002) and increase in
apoptosis (p = 0.0001, n = 6; Figure 1) when
compared with vehicle. When exposed to a
tenfold greater concentration of stauros-
porine (100 nM) for 28 hours, the viability
of immortalized mesangial cells was markedly
reduced to below 40% (p <0.0001, n = 6;
Figure 1), whilst the rate of apoptosis rose to
almost 50% (p <0.0001).
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DISCUSSION
A significant effect was observed from the
vehicle alone, when evaluating cell viability
(p <0.0001). From the above data, it was
determined that treatment of immortalized
mesangial cells with staurosporine at 10 nM
for 24 hours appeared to achieve the ma-
ximum increase in the rate of apoptosis whilst
still retaining a cell viability level of greater
than 75%. Therefore, this treatment regimen
was to be utilized as the principle method of
inducing apoptosis for testing the effect of
protease inhibition in the subsequent
experiments.13,14
The effect of the HIV-1 protease inhibitor
Ac-Leu-Val-phenylalanine (PI; Calbiochem,
CA, USA) on the rate of staurosporine-induced
apoptosis was then examined. Cells were
cultivated in 24-well plates as described above.
After reaching a confluence of around 80-90%,
the cells were treated for 24 hours with one of
the following: i) vehicle (methanol, 20 µl); ii)
staurosporine (10 nM); iii) protease inhibitor
(900 nM – this concentration is the pCI
50
 for
this drug); iv) staurosporine (10 nM) plus
protease inhibitor (900 nM). Incubation of
immortalized mesangial cells with PI alone for
2 hours had no acute effect on cell viability or
the rate of apoptosis, when compared with
vehicle controls (Figure 2). Increasing the time
of incubation to 24 hours (to coincide with
the incubation time required for staurosporine-
induced apoptosis) had no significant effect on
either the viability or rate of apoptosis (Figure
2). Incubation of the cells with 10 nM stauros-
porine, which was the concentration shown to
induce a significant amount of apoptosis in
preliminary experiments, again caused a
significant rise in the rate of apoptosis observed,
with a slight decrease in the viability. However,
Figure 1. Effect of the broad-spectrum protein kinase inhibitor staurosporine (stauro, n = 6 per group) or vehicle (DMSO, n =
6 per group) on viability and apoptosis in immortalized mesangial cells in culture. **, p <0.01; ***, p <0.001, 1-way ANOVA
with Bonferroni post-hoc test for multiple comparisons.
Figure 2. Effect of the HIV-1 viral protease inhibitor Ac-Leu-Val-phenylalanine (PI) or vehicle (methanol) on viability and apoptosis in the absence and presence of the broad-spectrum protein
kinase inhibitor staurosporine (n = 4 per group). *, p <0.05; 1-way ANOVA with Bonferroni post-hoc test for multiple comparisons.
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in these experiments the effect of staurosporine
alone on inducing apoptosis in immortalized
mesangial cells was significantly less than in the
preliminary initial experiments (Figures 1 and
2). The reason for this decreased effectiveness
of staurosporine is not understood. The only
difference between the two protocols is the fact
that in these latter experiments, staurosporine
was dissolved in a methanol vehicle, whilst
previously the staurosporine had been prepared
as a solution with viability comparable to that
of the vehicle. Therefore, whilst it is unlikely,
the difference in vehicle may be causing a
difference in the potency of this drug. Co-
incubation of the cells with staurosporine and
PI for 24 hours had no significant effect on
the rate of apoptosis, although cell viability
was significantly decreased in comparison
with staurosporine alone (p = 0.0222, n = 4;
Figure 2).
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CONCLUSION
It could therefore be seen that, in immor-
talized mesangial cells, staurosporine-induced
apoptosis was not significantly affected by the
HIV-1 viral protease inhibitor Ac-Leu-Val-
phenylalanine. This suggests that this
protease inhibitor would be ineffective in
preventing the late stages of progressive
glomerular sclerosis.
1. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z. Apoptosis
in glomerular sclerosis. Kidney International 1996;49:103-11.
2. Wang W, Tzanidis A, Divjak M, Thomson NM, Stein-Oakley
AN. Altered signaling and regulatory mechanisms of apoptosis
in focal and segmental glomerulosclerosis Journal of the
American Society of Nephrology 2001;12(7):1422-33.
3. Daha MR. Mechanisms of mesangial injury in glomerular
diseases. Journal of Nephrology 2000;3:89-95.
4. Haas CS, Schocklmann HO, Lang S, Krelewski M, Sterzel, RB.
Regulatory mechanism in glomerular mesangial cell
proliferation. Journal of Nephrology 1999;12(6):405-15.
5. Ortiz A. Nephrology forum: apoptotic regulatory proteins in
renal injury. Kidney International 2000;58(1):467-85.
○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
REFERENCES
6. Savill J. Apoptosis in post-streptococcal glomerulonephritis.
Kidney International 2001;60(3):1203-14.
7. Thompson EB. Special topic: apoptosis. Annual Reviews in
Physiology 1998;60:525-32.
8. Thornberry NA, Lazenbrik Y. Caspases: enemies within. Science
1998;281:1312-16.
9. Amstad PA, Yu G, Johnson GL, Lee BW, Dhawan S, Phelps
DJ. Detection of caspases activation in situ fluorochrome-
labeled caspase inhibitors. Biotechniques 2001;31(3):608-10.
10. Pong K, Doctrow SR, Huffman K, Adinolf CA, Baudry M.
Attenuation of staurosporine-induced apoptosis, oxidative stress,
and mitochondrial dysfunction by synthetic superoxide
dismutase and catalase mimetics, in cultured cortical neurons.
Experimental Neurology 2001;171(1):84-97.
11. Gorman A, McCarthy J, Finucane D, Reville W, Cotter TG.
Morphological assessment of apoptosis. In: Cotter TG,  Martin
SJ, editors. Techniques in apoptosis: a user’s guide. London:
Portland Press; 1996:1-20.
12. Caponigro F, French RC, Kaye SB. Protein kinase C: a worthwhile
target for anticancer drugs? Anticancer Drugs 1997;8:26-33.
13. Tee AR, Proud CG. Staurosporine inhibits phosphorylation of
translational regulators linked to mTOR. Cell Death
Differentiation 2001;8(8):841-9.
14. Fujita E, Egashira J, Urase K, Kuida K, Momoi T. Caspase-9
processing by caspase-3 via a feedback amplification loop in
vivo. Cell Death Differentiation 2001;8(4):335-44.
CONTEXTO: A glomeruloesclerose progressiva
(GEP) é uma situação caracterizada pela acu-
mulação de matriz extracelular glomerular e
pela diminuição no número de células no
glomérulo. Os mecanismos envolvidos na per-
da progressiva do número glomerular da célu-
la não são bem compreendidos, mas podem
envolver o processo da apoptose. Os princi-
pais mediadores na evolução da apoptose são
uma classe de enzimas de protease chamadas
caspases. Não se sabe como outros inibidores
de proteases com potencial uso terapêuticos
efetuam a cascata dos caspases e, conseqüen-
temente, se podem ser eficazes em impedir a
apoptose nos estágios anteriores da
glomeruloesclerose progressiva.
OBJETIVO: Avaliar se um inibidor da protease
HIV-1 viral (Ac-Leu-Val-phenylalanine; o PI)
poderia prevenir a apoptose em células me-
sangiais glomerulares imortalizadas.
TIPO DE ESTUDO: Estudo experimental
LOCAL: Disciplina de Nefrologia da Universi-
dade Federal de São Paulo/Escola Paulista de
Medicina, São Paulo, Brasil.
PARTICIPANTES: Células Mesangiais Imorta-
lizadas.
PROCEDIMENTOS: Cultura de Célula.
VARIÁVEIS ESTUDADAS: Viabilidade e taxa
de apoptose.
RESULTADOS: As células mesangiais imortali-
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zadas foram tratadas com a estaurosporina
(10-100 nM por 8 a 28h) para induzir a
apoptose. A estaurosporina (10 nM; 8 h) não
teve nenhum efeito viável, mas causou um
significativo aumento na taxa de apoptose (p
= 0,0411, n = 6). O aumento do tempo de
incubação proporcionou um grande aumen-
to da taxa de apoptose (p = 0,0001, n = 6),
entretanto, há também uma significativa di-
minuição da viabilidade (p = 0,0002). O au-
mento da concentração de estaurosporina 100
nM resultou em aumento da apoptose (p
<0,0001), porém com níveis inaceitáveis de
viabilidade (< 40%, p <0,0001, n = 6).
CONCLUSÕES: A incubação de células
mesangiais imortalizadas com PI (900 nM)
isolado por 2-24 h não teve efeito na viabili-
dade celular nem na taxa de apoptose com-
parada aos meios de controle (metanol). Co-
incubação das células com estaurosporina (10
nM) e PI por 24 horas não adicionou efeito
significativo na taxa de apoptose. Conseqüen-
temente, nas células mesangiais imortaliza-
das a apoptose induzida por estaurosporina
não foi afetada significativamente pelo
inibidor viral da protease HIV-1 Ac-Leu-Val-
phenylalanine.
PALAVRAS-CHAVE: Célula mesangial imorta-
lizada. Glomeruloesclerose progressiva.
Apoptose.
